Sustained-release anti-inflammatory therapy is valuable in noninfectious uveitis
Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.
Pediatric ophthalmologists target inherited retinal diseases
New opportunities continue to develop in an evolving landscape.
Gaining a greater understanding of AMD
Why investigators are considering AMD to be a disease spectrum rather than a single disease.
VEGF and beyond: therapeutic targeting in retinal vascular disorders
Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
Laser imaging system may offer early detection, treatment for eye diseases that cause blindness
According to investigators, the new technology is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.
Analyzing clinical results of dexamethasone implant effect on macular thickness
Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.
2 Clarke Drive Cranbury, NJ 08512